查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863491

泌尿系統護理設備和平台市場（按產品類型、應用、最終用戶、手術類型和技術分類）－2025-2032年全球預測

Urology Care Devices & Platforms Market by Product Type, Application, End User, Procedure Type, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，泌尿系統護理設備和平台市場將成長至 765.8 億美元，複合年成長率為 6.08%。

關鍵市場統計數據
基準年 2024 477.4億美元
預計年份：2025年 505.9億美元
預測年份 2032 765.8億美元
複合年成長率 (%) 6.08%

本書精闢地介紹了人口壓力、臨床創新和不斷變化的醫療模式如何重新定義泌尿系統器械和平台的發展重點。

現代泌尿系統生態系統正處於一個轉折點，臨床需求、技術創新和不斷演變的醫療服務模式在此交匯融合。人口老化和慢性泌尿系統系統疾病的盛行率上升推動了臨床病例數量的成長，而診斷技術、影像學和微創手術的進步正在改變臨床醫生檢測、治療和管理疾病的方式。同時，醫療系統日益注重價值導向，推動醫療機構和設備朝向能夠縮短住院時間、降低併發症率並支持門診和居家醫療的方向發展。

在此背景下，醫療設備開發商和平台提供者正在重新思考產品架構、連接方式和服務模式。數位化正在加速醫療設備的智慧化進程，從而實現更精準的診斷並促進遠端監測。同時，法規結構和支付模式也在不斷發展，以應對安全性、真實世界數據和基於結果的報銷等問題，這影響著研發重點和商業化策略。這些趨勢正在重塑研發投資、供應商夥伴關係和臨床應用路徑。

展望未來，能夠整合臨床證據、互通性並採用以患者為中心的設計的相關人員將最有能力影響醫療路徑。此外，積極協調供應鏈韌性和監管準備工作的組織將能夠減輕中斷影響並維持其創新管道。本執行摘要的其餘部分說明探討結構性變化、細分市場的影響、區域差異以及應對此快速變化環境的建議措施。

對正在重塑泌尿系統臨床路徑、設備設計和商業性重點的重大技術和製度變革進行深入分析。

泌尿系統器械和平台格局正經歷重大變革，這些變革既包括技術層面，也包括系統層面。首先，內視鏡光學技術的改進、雷射碎石術的進步以及高解析度成像系統的發展，推動了微創影像導引手術的成熟，提高了診斷準確性並減少了手術併發症。因此，臨床路徑越來越重視促進復健和實現門診治療的介入措施。

其次，數位技術和數據驅動能力正從輔助功能轉變為核心產品差異化因素。互聯診斷設備、雲端工作流程平台和人工智慧輔助影像分析正在提高診斷效率，並支援更個人化的治療方案。這些能力也不斷產生真實世界證據，而支付方和監管機構也開始要求提供這些證據，這將影響報銷和實施時間表。

第三，醫療服務模式日趨分散化。門診手術中心、診斷中心和家庭護理的重要性日益凸顯，推動了導管技術、攜帶式影像設備和小型體外碎石系統的重新設計。最後，監管機構對上市後監管和互通性標準的重視正在影響產品藍圖和供應商聯盟，製造商在重視臨床性能的同時，也優先考慮合規性和資料安全。這些變化共同塑造了一個全新的格局：技術卓越、互通性和對新醫療環境的適應能力將決定企業的長期競爭力。

對 2025 年美國關稅制度如何重塑泌尿系統器械製造的供應鏈、籌資策略和業務永續營運韌性進行分析評估。

美國關稅將於2025年生效，對整個泌尿系統醫療設備及平台價值鏈產生多面向影響。關稅帶來的成本壓力不僅限於成品，還波及影像處理子系統、雷射模組和一次性導管材料等關鍵零件。因此，採購團隊和產品經理面臨新的挑戰：重新評估供應商組合、重新計算總到岸成本，並加快替代供應商的資格認證。

這些趨勢也將對策略決策產生影響。為避免關稅波動的影響，製造商可能會尋求擴大本地生產或近岸外包，這將需要資本投資和重新思考供應鏈規劃。同時，透過採購整合和長期供應協議來節省採購成本可以部分抵消不斷上漲的投入成本，但這些安排需要嚴格的合約管理和品質監控。

醫療專業人員和供應商將受到間接影響，採購限制和庫存管理挑戰會影響醫療設備的供應和前置作業時間。為了減少對臨床營運的干擾，各機構正在優先實施供應鏈視覺化工具、安全庫存通訊協定和多源策略。此外，成本上升也可能影響創新路徑，因為研發預算將重新分配到使用標準化、免稅零件的模組化設計。總而言之，關稅將促進供應鏈轉型、策略營運調整以及加強製造業韌性。

透過整合產品類型、臨床應用、最終用戶、手術類型和底層技術進行全面的細分分析，為有針對性的策略決策提供支援。

在泌尿系統領域，深入的市場細分對於了解產品開發重點、臨床應用和服務至關重要。本市場研究以產品類型，涵蓋診斷設備、內視鏡、影像設備、體外碎石設備、尿道導管和尿道支架。診斷設備進一步細分為生物標記檢測、pH計、尿流率計和尿動力學檢查系統。內視鏡檢驗包括膀胱鏡、腎臟鏡和輸尿管鏡。影像設備包括CT掃描系統、MRI系統、超音波系統和X光系統。體外碎石技術包括體外震波碎石、雷射碎石、氣壓碎石和超音波碎石。尿道導管也進行了全面分析，包括尿套式導管、 Foley導管、間歇性導尿管、腎造瘻導管和輸尿管導管。對尿道支架進行了全面檢查，包括前列腺支架、輸尿管支架和尿道支架。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的診斷技術應用於前列腺癌和腎結石的早期檢測
  • 推出遠距泌尿系統平台，提供遠距會診和病患監測
  • 開發專門用於複雜泌尿系統手術的微創機器人手術系統
  • 穿戴式尿失禁監測設備的普及率不斷提高，這些設備可提供即時分析數據，從而最佳化治療方案。
  • 推出先進的智慧導管解決方案，旨在減少感染疾病並提高患者舒適度
  • 擴展照護現場檢測平台，用於快速診斷尿道感染
  • 雲端基礎的病患管理軟體實現泌尿系統護理協調與分析的一體化

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章泌尿系統護理設備與平台市場（依產品類型分類）

  • 診斷
    • 生物標記檢測
    • pH計
    • 尿流量計
    • 尿動力學測試系統
  • 內視鏡檢查
    • 膀胱鏡
    • 腎鏡
    • 輸尿管鏡
  • 影像診斷
    • 電腦斷層掃描系統
    • 磁振造影系統
    • 超音波診斷設備
    • X光系統
  • 體外碎石術
    • 體外震波碎石術
    • 雷射碎石術
    • 氣動碎石術
    • 超音波碎石術
  • 導尿管
    • 保險套導尿管
    • Foley導管
    • 間歇性導尿管
    • 腎造瘻管
    • 輸尿管導管
  • 尿路支架
    • 攝護腺支架
    • 輸尿管支架
    • 尿道支架

第9章泌尿系統護理設備和平台市場（按應用領域分類）

  • 良性攝護腺增生
  • 腎癌
    • 腎臟細胞癌
    • 移行細胞癌
    • 威爾姆氏腫瘤
  • 腎結石治療
    • 鈣結石
    • 胱氨酸結石
    • 鳥糞石
    • 尿酸結石
  • 膀胱過動症
    • 特發性
    • 神經源性
  • 攝護腺癌
    • 在地化
    • 轉移性
    • 復發
  • 尿道狹窄
    • 醫源性
    • 特發性
    • 創傷
  • 尿失禁
    • 混合性尿失禁
    • 溢出性尿失禁
    • 應力性尿失禁
    • 急性尿失禁
  • 尿道感染
    • 併發症
    • 無併發症

第10章泌尿系統護理設備與平台市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 診斷中心
  • 居家醫療
  • 醫院

第11章泌尿系統護理設備與平台市場（依手術類型分類）

  • 侵入性
    • 導管介入治療
    • 開放性手術
  • 微創
    • 內視鏡手術
    • 腹腔鏡手術
    • 經皮手術
  • 非侵入性
    • 保守治療
    • 體外震波療法
    • 影像診斷

第12章泌尿系統護理設備與平台市場（依技術分類）

  • 電液式
    • 高頻電液
    • 標準電液
  • 雷射
    • 二氧化碳雷射
    • 綠色雷射
    • 鈥雷射
    • 铥雷射
  • 磁振造影
    • 磁共振波譜
    • 磁共振引導磁共振
  • 光學
    • 螢光光學
    • 窄頻成像
    • 白光光學
  • 氣壓
    • 彈道氣壓
    • 振動氣動
  • 高頻
    • 雙極射頻
    • 單極射頻
  • 超音波
    • 高強度超音波
    • 低強度超音波

第13章泌尿系統護理設備與平台市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章泌尿系統護理設備與平台市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國泌尿系統護理設備與平台市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • Olympus Corporation
    • Medtronic plc
    • Coloplast A/S
    • Becton, Dickinson and Company
    • Teleflex Incorporated
    • ConvaTec Group plc
    • Intuitive Surgical, Inc.
    • Stryker Corporation
    • Johnson & Johnson
Product Code: MRR-5C6F41F5B0B4

The Urology Care Devices & Platforms Market is projected to grow by USD 76.58 billion at a CAGR of 6.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 47.74 billion
Estimated Year [2025] USD 50.59 billion
Forecast Year [2032] USD 76.58 billion
CAGR (%) 6.08%

An incisive introduction to how demographic pressures, clinical innovation, and shifting care models are redefining urology device and platform priorities

The contemporary urology care ecosystem is at an inflection point where clinical demand, technological innovation, and delivery model evolution intersect. Aging populations and rising prevalence of chronic urological conditions are expanding clinical caseloads, while advances in diagnostics, imaging, and minimally invasive therapies are changing how clinicians detect, treat, and manage disease. At the same time, health systems emphasize value, driving a shift toward procedures and devices that reduce length of stay, lower complication rates, and support outpatient and home-based care.

Against this backdrop, device developers and platform providers are rethinking product architecture, connectivity, and service models. Digitalization is accelerating device intelligence, enabling more precise diagnostics and facilitating remote monitoring. Concurrently, regulatory frameworks and payer models are evolving to address safety, real-world evidence, and outcomes-based reimbursement, which in turn influence development priorities and commercialization strategies. These dynamics are reshaping R&D investment, vendor partnerships, and clinical adoption pathways.

Looking ahead, stakeholders who can integrate clinical evidence, interoperability, and patient-centered design will be best positioned to influence care pathways. In addition, organizations that proactively align supply chain resilience with regulatory preparedness will mitigate disruption and sustain innovation pipelines. The remainder of this executive summary unpacks the structural shifts, segmentation implications, regional nuances, and recommended actions to navigate this rapidly changing landscape.

A detailed exploration of the major technological and systemic shifts reshaping clinical pathways, device design, and commercial priorities across urology care

Significant transformative shifts are reconfiguring the urology devices and platforms landscape, and these changes are both technological and systemic. First, minimally invasive and image-guided procedures have matured, driven by enhancements in endoscopic optics, laser lithotripsy modalities, and high-resolution imaging systems that raise diagnostic confidence while lowering procedural morbidity. As a result, clinical pathways are increasingly favoring interventions that accelerate recovery and enable outpatient delivery.

Second, digital and data-driven capabilities are moving from adjunct features to core product differentiators. Connected diagnostics, cloud-enabled workflow platforms, and artificial intelligence-supported image interpretation are elevating diagnostic throughput and supporting more personalized treatment planning. These capabilities also produce real-world evidence that payers and regulators are beginning to demand, thereby influencing reimbursement and adoption timelines.

Third, the locus of care is decentralizing. Ambulatory surgical centers, diagnostic centers, and home-based management are becoming more prominent, prompting redesigns in catheter technologies, portable imaging, and compact lithotripsy systems. Lastly, regulatory emphasis on post-market surveillance and interoperability standards is shaping product roadmaps and vendor partnerships, with manufacturers prioritizing compliance and data security alongside clinical performance. Taken together, these shifts create a landscape where technological excellence, interoperability, and adaptability to new care settings determine long-term competitiveness.

An analytical assessment of how the United States tariff regime implemented in 2025 is reshaping supply chains, sourcing strategies, and operational resilience in urology device manufacturing

The introduction of United States tariffs in 2025 exerts a multi-dimensional influence across the urology devices and platforms value chain. Tariff-driven cost pressures affect not only finished devices but also critical components such as imaging subsystems, laser modules, and disposable catheter materials. Consequently, procurement teams and product managers face renewed imperative to reassess supplier portfolios, re-evaluate total landed costs, and accelerate supplier qualification for alternative sources.

These dynamics also influence strategic decision-making. Manufacturers may pursue increased regional manufacturing or nearshoring to insulate operations from tariff volatility, which requires capital expenditure and modified supply chain planning. At the same time, procurement savings from consolidated sourcing or longer-term supplier agreements can partially offset higher input costs, but such arrangements require disciplined contract management and rigorous quality oversight.

Clinicians and providers experience indirect effects as procurement constraints and inventory management challenges influence device availability and lead times. To mitigate clinical disruption, organizations are prioritizing supply chain visibility tools, safety stock protocols, and multi-sourcing strategies. Finally, innovation pathways can be affected, since cost escalation prompts reallocation of R&D budgets toward modular designs that leverage standardized, tariff-exempt components. In sum, tariffs act as a catalyst for supply chain transformation, strategic operational shifts, and heightened emphasis on manufacturing resilience.

Comprehensive segmentation insights that align device categories, clinical applications, end users, procedure types, and enabling technologies to inform targeted strategic decisions

Insightful segmentation is essential to understanding product development priorities, clinical adoption, and service delivery across the urology landscape. Based on Product Type, market studies encompass Diagnostics, Endoscopes, Imaging, Lithotripsy, Urinary Catheters, and Urinary Stents; Diagnostics is further studied across Biomarker Assays, PH Meters, Urinary Flow Meters, and Urodynamic Systems; Endoscopes is examined through Cystoscopes, Nephroscopes, and Ureteroscopes; Imaging is analyzed across CT Scanning Systems, MRI Systems, Ultrasound Systems, and X Ray Systems; Lithotripsy is explored through Extracorporeal Shockwave Lithotripsy, Laser Lithotripsy, Pneumatic Lithotripsy, and Ultrasonic Lithotripsy; Urinary Catheters are reviewed across Condom Catheters, Foley Catheters, Intermittent Catheters, Nephrostomy Catheters, and Ureteral Catheters; and Urinary Stents are considered across Prostatic Stents, Ureteral Stents, and Urethral Stents.

Based on Application, the analysis spans Benign Prostatic Hyperplasia, Kidney Cancer, Kidney Stone Management, Overactive Bladder, Prostate Cancer, Urethral Stricture, Urinary Incontinence, and Urinary Tract Infection; Kidney Cancer is further delineated into Renal Cell Carcinoma, Transition Cell Carcinoma, and Wilms Tumor; Kidney Stone Management differentiates across Calcium Stones, Cystine Stones, Struvite Stones, and Uric Acid Stones; Overactive Bladder is categorized as Idiopathic and Neurogenic; Prostate Cancer is differentiated into Localized, Metastatic, and Recurrent; Urethral Stricture is classified as Iatrogenic, Idiopathic, and Traumatic; Urinary Incontinence is segmented into Mixed Incontinence, Overflow Incontinence, Stress Incontinence, and Urge Incontinence; and Urinary Tract Infection is analyzed as Complicated and Uncomplicated.

Based on End User, the study targets Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Home Care, and Hospitals, illuminating how purchasing patterns and care pathways differ across those settings. Based on Procedure Type, the framework separates Invasive, Minimally Invasive, and Non Invasive approaches; Invasive procedures include Catheterization Interventions and Open Surgery; Minimally Invasive procedures encompass Endoscopic Procedures, Laparoscopic Procedures, and Percutaneous Procedures; and Non Invasive management includes Conservative Management, External Shockwave Therapy, and Imaging. Finally, based on Technology, the research evaluates Electrohydraulic, Laser, Magnetic Resonance, Optical, Pneumatic, RF, and Ultrasonic platforms; Electrohydraulic distinguishes High Frequency Electrohydraulic and Standard Electrohydraulic; Laser differentiates CO2 Laser, Greenlight Laser, Holmium Laser, and Thulium Laser; Magnetic Resonance reviews MR Spectroscopy and MRI Guided MR; Optical considers Fluorescence Optical, Narrow Band Imaging, and White Light Optical; Pneumatic assesses Ballistic Pneumatic and Vibratory Pneumatic; RF examines Bipolar RF and Monopolar RF; and Ultrasonic explores High Intensity Ultrasonic and Low Intensity Ultrasonic. This layered segmentation enables targeted strategy development that aligns product features with clinical needs and care settings.

Regional strategic perspectives revealing how distinct regulatory, reimbursement, and care delivery priorities in the Americas, EMEA, and Asia-Pacific influence adoption and commercialization

Regional dynamics shape adoption timelines, reimbursement structures, and regulatory expectations, producing varied strategic imperatives across global markets. In the Americas, clinical emphasis on outpatient shift and bundled payment models incentivizes devices and platforms that reduce procedural cost and facilitate rapid recovery, while strong private payer participation accelerates uptake of premium technologies that demonstrate measurable outcomes. As a result, manufacturers targeting this region prioritize clinical-economic evidence and streamlined supply relationships.

In Europe, Middle East & Africa, heterogeneous regulatory pathways and public payer dominance create a complex environment where tendering mechanisms and national health technology assessments drive procurement decisions. Manufacturers operating across this region must balance centralized regulatory approvals with localized health economic arguments and partnerships with public providers. Meanwhile, medical infrastructure disparities across subregions necessitate modular product offerings and flexible service models.

In the Asia-Pacific region, rapid investment in healthcare capacity, a growing middle-class patient base, and a strong appetite for medical tourism create favorable conditions for advanced surgical platforms and diagnostic imaging. However, local manufacturing capabilities and cost-sensitive procurement practices often favor regional supply partnerships and technology transfer arrangements. Across all regions, interoperability, post-market surveillance, and local clinical evidence generation remain cross-cutting priorities that influence adoption and long-term product success.

A nuanced examination of how device manufacturers and platform providers are deploying technology, partnerships, and service models to strengthen competitive advantage

Key companies in the urology devices and platforms space are differentiating themselves through a combination of technological leadership, clinical partnerships, and integrated service offerings. Market-leading manufacturers increasingly couple capital equipment with consumables and data services to create recurring revenue streams and deepen customer relationships. This shift toward solution-oriented business models emphasizes long-term service agreements, remote monitoring capabilities, and bundled purchasing options that address provider priorities for reliability and total cost of ownership.

Strategic collaborations between device developers, digital health firms, and academic clinical centers are accelerating product validation and enhancing clinical utility. In parallel, targeted acquisitions and licensing arrangements enable faster access to complementary technologies such as advanced imaging modules, AI-enabled analytics, and novel lithotripsy modalities. Competitive differentiation arises from the ability to translate technological innovation into validated clinical outcomes and streamlined workflows that reduce procedural complexity.

Operational excellence also matters: firms with resilient supply chains, robust regulatory teams, and scalable manufacturing processes can respond faster to demand shifts and tariff-driven disruptions. Finally, customer-centric commercial strategies that include clinician training programs, procedure optimization support, and real-world evidence sharing will continue to influence procurement decisions and long-term adoption trajectories.

Actionable strategic imperatives for leaders to strengthen supply chain resilience, accelerate digital integration, and align commercial models with evolving provider needs

Industry leaders must act decisively to capture value and mitigate risk as the urology landscape evolves. First, diversify supply chain footprints and qualify alternative component suppliers to reduce exposure to tariff and geopolitical shocks while investing selectively in nearshoring where it improves lead times and quality control. Second, prioritize modular product designs that enable component standardization and cost-effective upgrades, thereby extending product lifecycles and simplifying regulatory submissions.

Third, invest in digital capabilities that enhance diagnostic precision, procedural guidance, and post-procedure monitoring. Integrating cloud-based data platforms and AI-supported analytics will not only improve clinical outcomes but also generate the evidence required for payer engagement. Fourth, design commercialization strategies that reflect end-user heterogeneity: tailor product configurations and service levels for ambulatory surgical centers, hospitals, diagnostic centers, clinics, and home care settings to maximize adoption.

Fifth, engage early with regulatory bodies and health technology assessors to align study designs with evidentiary expectations and expedite reimbursement pathways. Sixth, expand clinician training and proctoring programs to shorten adoption curves and demonstrate real-world value. Finally, develop flexible pricing and contracting models that support outcomes-based arrangements and lifecycle service commitments, enabling customers to share risk and align incentives across the care continuum.

A transparent and multi-method research approach combining clinician input, regulatory review, and supply chain analysis to validate strategic conclusions and recommendations

The research methodology underpinning this analysis combines multiple evidence streams to ensure robust, actionable insights. Primary research included structured interviews and advisory engagements with practicing urologists, hospital procurement executives, ambulatory care administrators, and device development leaders to capture frontline perspectives on clinical needs, adoption barriers, and procurement drivers. These qualitative inputs were complemented by a systematic review of recent clinical literature, regulatory filings, and procedural guidelines to ground findings in current practice and safety requirements.

Secondary analysis encompassed technology landscape mapping, patent review, and device labeling assessments to identify feature differentials and technological trajectories. Supply chain and manufacturing analyses examined component sourcing, regulatory compliance pathways, and tariff exposure to evaluate operational risks. Data triangulation ensured consistency across sources, while expert validation sessions with multi-disciplinary panels tested assumptions and refined strategic recommendations.

In addition, case-based scenario planning was used to explore the implications of policy shifts, reimbursement changes, and technology disruptions on adoption timelines and commercial success. Throughout the methodology, emphasis was placed on transparent documentation of data sources, qualification criteria for interviewees, and the limitations inherent to evolving clinical and regulatory environments.

A compelling conclusion that synthesizes key insights and underscores strategic priorities for stakeholders seeking to navigate complexity and capture growth opportunities

In closing, the urology devices and platforms sector is entering a period characterized by both significant opportunity and heightened complexity. Technological advances in imaging, endoscopy, and lithotripsy are enabling safer, more effective interventions, while digital tools and connectivity are transforming diagnostics and post-procedural management. At the same time, external pressures such as tariff regimes, supply chain constraints, and evolving reimbursement expectations demand proactive strategic responses from manufacturers and providers alike.

Organizations that succeed will be those that integrate clinical evidence generation, adaptable product architectures, and resilient operational models. Equally important will be the capacity to customize offerings to disparate care settings and regional market nuances, and to demonstrate measurable clinical and economic value to payers and health systems. For stakeholders willing to invest in interoperability, clinician engagement, and modular innovation, the changing landscape presents clear pathways to competitive differentiation and sustainable growth.

The insights and recommendations provided here are intended to inform near-term tactical decisions and longer-term strategic planning, empowering leaders to navigate uncertainty while capitalizing on the most promising avenues for clinical impact and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven diagnostics for early detection of prostate cancer and kidney stones
  • 5.2. Adoption of teleurology platforms to deliver remote urological consultations and patient monitoring
  • 5.3. Development of minimally invasive robotic-assisted surgical systems tailored to complex urological procedures
  • 5.4. Growth of wearable urinary incontinence monitoring devices offering real-time analytics for treatment optimization
  • 5.5. Launch of advanced smart catheter solutions designed to reduce infections and enhance patient comfort
  • 5.6. Expansion of point-of-care molecular testing platforms enabling rapid urinary tract infection diagnosis
  • 5.7. Utilization of cloud-based patient management software for integrated urology care coordination and analytics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Care Devices & Platforms Market, by Product Type

  • 8.1. Diagnostics
    • 8.1.1. Biomarker Assays
    • 8.1.2. PH Meters
    • 8.1.3. Urinary Flow Meters
    • 8.1.4. Urodynamic Systems
  • 8.2. Endoscopes
    • 8.2.1. Cystoscopes
    • 8.2.2. Nephroscopes
    • 8.2.3. Ureteroscopes
  • 8.3. Imaging
    • 8.3.1. CT Scanning Systems
    • 8.3.2. MRI Systems
    • 8.3.3. Ultrasound Systems
    • 8.3.4. X Ray Systems
  • 8.4. Lithotripsy
    • 8.4.1. Extracorporeal Shockwave Lithotripsy
    • 8.4.2. Laser Lithotripsy
    • 8.4.3. Pneumatic Lithotripsy
    • 8.4.4. Ultrasonic Lithotripsy
  • 8.5. Urinary Catheters
    • 8.5.1. Condom Catheters
    • 8.5.2. Foley Catheters
    • 8.5.3. Intermittent Catheters
    • 8.5.4. Nephrostomy Catheters
    • 8.5.5. Ureteral Catheters
  • 8.6. Urinary Stents
    • 8.6.1. Prostatic Stents
    • 8.6.2. Ureteral Stents
    • 8.6.3. Urethral Stents

9. Urology Care Devices & Platforms Market, by Application

  • 9.1. Benign Prostatic Hyperplasia
  • 9.2. Kidney Cancer
    • 9.2.1. Renal Cell Carcinoma
    • 9.2.2. Transition Cell Carcinoma
    • 9.2.3. Wilms Tumor
  • 9.3. Kidney Stone Management
    • 9.3.1. Calcium Stones
    • 9.3.2. Cystine Stones
    • 9.3.3. Struvite Stones
    • 9.3.4. Uric Acid Stones
  • 9.4. Overactive Bladder
    • 9.4.1. Idiopathic
    • 9.4.2. Neurogenic
  • 9.5. Prostate Cancer
    • 9.5.1. Localized
    • 9.5.2. Metastatic
    • 9.5.3. Recurrent
  • 9.6. Urethral Stricture
    • 9.6.1. Iatrogenic
    • 9.6.2. Idiopathic
    • 9.6.3. Traumatic
  • 9.7. Urinary Incontinence
    • 9.7.1. Mixed Incontinence
    • 9.7.2. Overflow Incontinence
    • 9.7.3. Stress Incontinence
    • 9.7.4. Urge Incontinence
  • 9.8. Urinary Tract Infection
    • 9.8.1. Complicated
    • 9.8.2. Uncomplicated

10. Urology Care Devices & Platforms Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Home Care
  • 10.5. Hospitals

11. Urology Care Devices & Platforms Market, by Procedure Type

  • 11.1. Invasive
    • 11.1.1. Catheterization Interventions
    • 11.1.2. Open Surgery
  • 11.2. Minimally Invasive
    • 11.2.1. Endoscopic Procedures
    • 11.2.2. Laparoscopic Procedures
    • 11.2.3. Percutaneous Procedures
  • 11.3. Non Invasive
    • 11.3.1. Conservative Management
    • 11.3.2. External Shockwave Therapy
    • 11.3.3. Imaging

12. Urology Care Devices & Platforms Market, by Technology

  • 12.1. Electrohydraulic
    • 12.1.1. High Frequency Electrohydraulic
    • 12.1.2. Standard Electrohydraulic
  • 12.2. Laser
    • 12.2.1. CO2 Laser
    • 12.2.2. Greenlight Laser
    • 12.2.3. Holmium Laser
    • 12.2.4. Thulium Laser
  • 12.3. Magnetic Resonance
    • 12.3.1. MR Spectroscopy
    • 12.3.2. MRI Guided MR
  • 12.4. Optical
    • 12.4.1. Fluorescence Optical
    • 12.4.2. Narrow Band Imaging
    • 12.4.3. White Light Optical
  • 12.5. Pneumatic
    • 12.5.1. Ballistic Pneumatic
    • 12.5.2. Vibratory Pneumatic
  • 12.6. RF
    • 12.6.1. Bipolar RF
    • 12.6.2. Monopolar RF
  • 12.7. Ultrasonic
    • 12.7.1. High Intensity Ultrasonic
    • 12.7.2. Low Intensity Ultrasonic

13. Urology Care Devices & Platforms Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Urology Care Devices & Platforms Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Urology Care Devices & Platforms Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Olympus Corporation
    • 16.3.3. Medtronic plc
    • 16.3.4. Coloplast A/S
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. Teleflex Incorporated
    • 16.3.7. ConvaTec Group plc
    • 16.3.8. Intuitive Surgical, Inc.
    • 16.3.9. Stryker Corporation
    • 16.3.10. Johnson & Johnson

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. UROLOGY CARE DEVICES & PLATFORMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. UROLOGY CARE DEVICES & PLATFORMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLOGY CARE DEVICES & PLATFORMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BIOMARKER ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PH METERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY FLOW METERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URODYNAMIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CT SCANNING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY X RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PNEUMATIC LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY ULTRASONIC LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CONDOM CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEPHROSTOMY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URINARY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URETHRAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY RENAL CELL CARCINOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY TRANSITION CELL CARCINOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY WILMS TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY KIDNEY STONE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CALCIUM STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY OVERACTIVE BLADDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY IDIOPATHIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL UROLOGY CARE DEVICES & PLATFORMS MARKET SIZE, BY NEUROGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL UROLOGY CARE DEVICES & PLATFORMS M